ADREXpharma and Mother Labs will introduce a line of cannabis flower brands to the German medical market under the "Mother Labs" name.
Nicole Broockmann CEO of ADREXpharma said: "This partnership represents a significant milestone in our mission to provide German medical patients with the highest quality cannabis products. Mother Labs' advanced genetic development capabilities perfectly complement our distribution and regulatory expertise."
The new "Mother Labs" branded flower line will initially launch with a selection of premium cannabis flowers, specifically designed to meet the needs of medical patients, and will be available through pharmacies across Germany.
For more information:
Mother Labs
www.motherlabs.ca
ADREXpharma 
adrexpharma.com
